Kappa Bioscience creates end-to-end solution with acquisition of ppm.Ingredients

摘要

Kappa Bioscience AS, maker of K2VITAL® vitamin <2 MK-7 has announced the acquisition of ppm.Ingredients KG (PPM), its long term European distributor. PPM will continue operations as Kappa Ingredients GmbH, effective immediately. By integrating a sales function, Kappa increases its overall competitiveness with the ability to work more closely with customers and partners. PPM supplies more than 100 different grades of four complementary ingredients: Vitamin K2 as MK-7, Calcium, Magnesium and Vitamin D3. Vitamin K2 products are marketed under the K2VITAL® portfolio, including the microencapsulated K2VITAL® DELTA. The acquisition instantly expands Kappa's product line and increases its in-house expertise of market solutions for bone and heart health products. This acquisition follows an earlier 2016 acquisition of Synthetica AS, another long-term partner specializing in drug and vitamin synthesis, analysis, and research and development.